Ashton Thomas Private Wealth, LLC Halozyme Therapeutics, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.9 Trillion
- Q3 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 3,791 shares of HALO stock, worth $182,460. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,791
Previous 3,720
1.91%
Holding current value
$182,460
Previous $195 Million
11.41%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$848 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$621 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$319 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$196 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$164 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.7B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...